BIOMAT Database Logo BIOMAT Database Logo

Design, Synthesis and In-vivo Anti-inflammatory Activity of New Celecoxib Analogues as NSAID. 2018

Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Applied Organic Chemistry Department, National Research Centre,12622, Dokki, Giza, Egypt.

BACKGROUND A new series of Celecoxib analogues were easily synthesized via reactions of 4-(2-(1-chloro-2-oxopropylidene)hydrazinyl)benzene sulfonamide (1) with active methylene compounds and dialkyl malonate. In addition, compound 1 was reacted also with thiourea derivatives and thiosemicarbazone derivatives to afford thiazole derivatives 9 and 11, respectively. Furthermore, triazolo pyrimidine derivatives 13 were prepared via reaction of compound 1 with pyrimidine thione derivatives. The structures of the new synthesized compounds were assigned by elemental analysis and spectroscopic data. The new analogues were screened for their in vivo anti-inflammatory activity using carrageenan-induced paw edema method. CONCLUSIONS They showed moderate to good in vivo anti-inflammatory effects. Compounds 1, 6 and 11b were the most active compounds that reduced the paw edema induced by carrageenan by 12.25 %, 12.96 % and 12.97% respectively, as compared to the Indomethacin that inhibited the oedema volume by 7.47 %.

UI MeSH Term Description Entries
D008297 Male Males
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000068579 Celecoxib A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN. 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,Celebrex,SC 58635,SC-58635,SC58635
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D052246 Cyclooxygenase 2 Inhibitors A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. COX-2 Inhibitor,COX2 Inhibitor,Coxib,Cyclooxygenase 2 Inhibitor,Cyclooxygenase-2 Inhibitor,COX-2 Inhibitors,COX2 Inhibitors,Coxibs,Cyclooxygenase-2 Inhibitors,2 Inhibitor, Cyclooxygenase,COX 2 Inhibitor,COX 2 Inhibitors,Inhibitor, COX-2,Inhibitor, COX2,Inhibitor, Cyclooxygenase 2,Inhibitor, Cyclooxygenase-2,Inhibitors, COX-2,Inhibitors, COX2,Inhibitors, Cyclooxygenase 2,Inhibitors, Cyclooxygenase-2

Related Publications

Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues.
September 2002, Bioorganic & medicinal chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Structure-based design, synthesis and preliminary anti-inflammatory activity of bolinaquinone analogues.
February 2011, European journal of medicinal chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Synthesis and anti-inflammatory activity of celecoxib like compounds.
October 2013, Journal of enzyme inhibition and medicinal chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
New celecoxib derivatives as anti-inflammatory agents.
January 2008, Journal of medicinal chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Synthesis of some new flurbiprofen analogues as anti-inflammatory agents.
January 2014, Anti-inflammatory & anti-allergy agents in medicinal chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Synthesis and anti-inflammatory activity of benzophenone analogues.
August 2004, Bioorganic chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A.
December 2006, Bioorganic & medicinal chemistry letters,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Design, synthesis and in vivo activity of 9-(S)-dihydroerythromycin derivatives as potent anti-inflammatory agents.
November 2006, Bioorganic & medicinal chemistry letters,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Design, synthesis and bioactivities of Celecoxib analogues or derivatives.
September 2017, Bioorganic & medicinal chemistry,
Naglaa A Abdel Hafez, and Korany A Ali, and Alhussein A Ibrahim, and Dina H Elnaggar, and Amany A Sleem
Synthesis and sar study of diarylpentanoid analogues as new anti-inflammatory agents.
October 2014, Molecules (Basel, Switzerland),
Copied contents to your clipboard!